We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+20.42%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.1B
AUM Growth
+$380M
(+14%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-34.94%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
89
New
16
Increased
13
Reduced
14
Closed
12
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
+$50.7M |
| 2 |
CG Oncology
CGON
|
+$46.2M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$42.3M |
| 4 |
Legend Biotech
LEGN
|
+$41.1M |
| 5 |
Transmedics
TMDX
|
+$40.9M |
Top Sells
| 1 |
Immunocore
IMCR
|
+$41.8M |
| 2 |
Lantheus
LNTH
|
+$30.7M |
| 3 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$30.6M |
| 4 |
Keros Therapeutics
KROS
|
+$22.6M |
| 5 |
Amgen
AMGN
|
+$16.8M |
Sector Composition
| 1 | Healthcare | 57.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apogee Therapeutics
APGE
$10.2B
| $122M | 3.95% |
1,842,515
+1,161,414
| +171% | +$50.7M |
|
2
Neurocrine Biosciences
NBIX
$17.3B
| $101M | 3.25% |
730,209
+15,000
| +2% | +$2.05M |
|
3
argenx
ARGX
$54B
| $86.5M | 2.79% |
219,824
+66,620
| +43% | +$25.8M |
|
4
Vaxcyte
PCVX
$8.19B
| $82.8M | 2.67% |
1,212,703
-77,262
| -6% | -$5.35M |
|
|
5
Legend Biotech
LEGN
$4.46B
| $69.8M | 2.25% |
1,243,795
+681,195
| +121% | +$41.1M |
|
6
Penumbra
PEN
$12.5B
| $66M | 2.13% |
295,892
+73,100
| +33% | +$18.1M |
|
7
Maravai LifeSciences
MRVI
$1.04B
| $62.6M | 2.02% |
7,221,960
+2,181,325
| +43% | +$14.8M |
|
8
Viking Therapeutics
VKTX
$4.39B
| $58.5M | 1.88% |
+713,100
| New | +$31.7M |
|
9
Xenon Pharmaceuticals
XENE
$6.55B
| $56.3M | 1.81% |
1,308,011
-339,300
| -21% | -$15.6M |
|
10
iRhythm Holdings
IRTC
$3.72B
| $56.1M | 1.81% |
483,257
-84,900
| -15% | -$9.54M |
|
11
Align Technology
ALGN
$13B
| $55.5M | 1.79% |
169,252
+22,939
| +16% | +$6.73M |
|
12
Guardant Health
GH
$21.6B
| $51.1M | 1.65% |
2,476,804
+1,717,876
| +226% | +$36.8M |
|
|
13
CG Oncology
CGON
$6.44B
| $49.6M | 1.6% |
+1,130,235
| New | +$46.2M |
|
|
14
Keros Therapeutics
KROS
$218M
| $48.8M | 1.57% |
737,379
-381,582
| -34% | -$22.6M |
|
|
15
Transmedics
TMDX
$2.61B
| $45.4M | 1.46% |
614,531
+496,830
| +422% | +$40.9M |
|
|
AVDL
16
DELISTED
Avadel Pharmaceuticals
AVDL
| $45.1M | 1.45% |
+2,668,549
| New | +$39.7M |
|
17
Glaukos
GKOS
$9.21B
| $42.5M | 1.37% |
450,676
+207,916
| +86% | +$18.6M |
|
|
FNA
18
DELISTED
Paragon 28, Inc.
FNA
| $41.6M | 1.34% |
3,365,609
+3,785
| +0.1% | +$45K |
|
19
Intuitive Surgical
ISRG
$138B
| $40.1M | 1.29% |
+100,500
| New | +$38M |
|
|
DAWN
20
DELISTED
Day One Biopharmaceuticals
DAWN
| $35.9M | 1.16% |
2,173,704
-2,041,869
| -48% | -$30.6M |
|
21
4D Molecular Therapeutics
FDMT
$611M
| $33.5M | 1.08% |
+1,052,485
| New | +$26.9M |
|
22
OrthoPediatrics
KIDS
$507M
| $32.3M | 1.04% |
1,107,770
| – | – |
|
23
Krystal Biotech
KRYS
$10.3B
| $31.5M | 1.02% |
177,089
-19,111
| -10% | -$2.65M |
|
24
Relay Therapeutics
RLAY
$4.25B
| $31.1M | 1% |
+3,743,999
| New | +$36.5M |
|
|
25
Ironwood Pharmaceuticals
IRWD
$658M
| $30.4M | 0.98% |
+3,489,843
| New | +$42.3M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM